PHYSIOLOGICAL PHARMACOKINETIC MODELING

被引:15
作者
BALANT, LP
GEXFABRY, M
机构
[1] Clinical Research Unit, Department of Psychiatry, University of Geneva
关键词
D O I
10.3109/00498259009046841
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The different types of models are described, with emphasis on the clearance-based one-compartment model, and on full physiological models which distinguish between a number of anatomical compartments interconnected through the body fluid system. 2. The clearance-based, one-compartment model incorporates physiological concepts, such as apparent volume of distribution, systemic availability, hepatic and renal clearance. As opposed to the classical rate constant-based model, it allows a study of the influence of plasma protein binding, hepatic intrinsic clearance and blood flow. The advantages of such an approach are illustrated in two typical situations, namely renal insufficiency and saturable protein binding. 3. In full physiological models each compartment represents a particular organ or tissue, further divided into vascular, interstitial and cellular spaces. Mass balance equations are written for each of these subcompartments. Shortcomings of such comprehensive models include difficulty in collecting tissue data, especially human, and sophisticated numerical techniques needed for parameter estimation. The main advantages are specific organ metabolism and transport, and the possibility of scaling up from animal to human. 4. The pharmacokinetic parameters important for new drug registration are also listed. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:1241 / 1257
页数:17
相关论文
共 28 条
[1]  
BALANT LP, 1983, INT J CLIN PHARM RES, V3, P459
[2]  
BALANT LP, 1990, ADV DRUG RES, V19, P1
[3]  
BALANT LP, 1983, DRUG FATE METABOLISM, V4, P1
[4]  
BISCHOFF KB, 1968, J PHARM SCI, V57, P1347
[5]  
BLAANT LP, 1986, PROTEIN BINDING DRUG, P231
[6]   INTERSPECIES PHARMACOKINETIC SCALING AND THE EVOLUTIONARY-COMPARATIVE PARADIGM [J].
BOXENBAUM, H .
DRUG METABOLISM REVIEWS, 1984, 15 (5-6) :1071-1121
[7]   INTERSPECIES VARIATION IN LIVER WEIGHT, HEPATIC BLOOD-FLOW, AND ANTIPYRINE INTRINSIC CLEARANCE - EXTRAPOLATION OF DATA TO BENZODIAZEPINES AND PHENYTOIN [J].
BOXENBAUM, H .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1980, 8 (02) :165-176
[8]   INTERSPECIES SCALING, ALLOMETRY, PHYSIOLOGICAL TIME, AND THE GROUND PLAN OF PHARMACOKINETICS [J].
BOXENBAUM, H .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (02) :201-225
[9]   EVOLUTIONARY BIOLOGY, ANIMAL BEHAVIOR, 4TH-DIMENSIONAL SPACE, AND THE RAISON DETRE OF DRUG-METABOLISM AND PHARMACOKINETICS [J].
BOXENBAUM, H .
DRUG METABOLISM REVIEWS, 1983, 14 (05) :1057-1097
[10]   PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING - PRINCIPLES AND APPLICATIONS [J].
GERLOWSKI, LE ;
JAIN, RK .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (10) :1103-1127